New Jersey Attorneys Who Get Results
Meet Gary Shapiro and David
Sternlieb, two experienced New Jersey attorneys who know how
to get results. At Shapiro & Sternlieb, we are 100% dedicated
to providing our clients with the highest quality legal representation.
Through our hard work, persistence and with more than 60 years
of combined legal experience, we work hard to protect your rights.
As expert lawyers, we have the resources and knowledge to handle
complex cases. We pride ourselves on our concern for you as
an individual as well as for your legal rights.
Shapiro & Sternlieb: New Jersey Personal Injury Lawyers
At Shapiro & Sternlieb, your case is our priority. Our attorneys
combine outstanding client services with a thorough knowledge of
the law and a firm understanding of the latest technology available.
Our vast network of legal, medical and professional experts are
available to present the best case for you. Located in Manalapan,
New Jersey, our lawyers maintain flexible hours to meet your needs.
We offer morning, evening or weekend hours, as well as visits
to home or hospital, if needed. Our attorneys and staff bring the
highest standards of expertise, preparation, concern, diligence,
integrity and skill to each case. We take time to return your calls
and to ensure each question is answered. You are included every
step of the way!
News & Articles
Practice Areas
|
FDA Consumer Health Information Updates
http://www.fda.gov/AboutFDA/ContactFDA/StayInformed/RSSFeeds/Consumers/rss.xml
Tue, 18 Jun 2013 13:00:00 -0400
This page contains the most recent Consumer Update data available and links to past Consumer Update Analytics web pages. |
Wed, 05 Jun 2013 10:00:00 -0400
Drug companies spend $25 billion a year in the U.S. promoting prescription medications, including a growing amount spent of direct-to-consumer advertising. Thomas Abrams, director of FDA’s Office of Prescription Drug Promotions (OPDP), discusses what his staff does to monitor for truth and balance. |
Tue, 04 Jun 2013 09:00:00 -0400
If you're part of what is called an "at-risk" or "vulnerable" population, a foodborne illness can be extremely dangerous. Learn which people are considered at risk and why, as well as safety precautions they can take to help prevent foodborne illness. |
Mon, 03 Jun 2013 13:30:00 -0400
The Food and Drug Administration (FDA) announces an initiative to get more consumers to report problems with drugs, devices and other products to MedWatch. |
Wed, 29 May 2013 00:00:00 -0400
During allergy season, many turn to antihistamines for relief of allergy symptoms. But some antihistamines can make you drowsy, unfocused and slow to react. Learn what precautions you should take when using antihistamines. |
Food and Drug Administration--Press Releases
http://www.fda.gov/AboutFDA/ContactFDA/StayInformed/RSSFeeds/PressReleases/rss.xml
Fri, 14 Jun 2013 15:38:00 -0400
The U.S. Food and Drug Administration today approved the MemoryShape Breast Implant to increase breast size (augmentation) for use in women at least 22 years old and to rebuild breast tissue (reconstruction) in women of any age. The MemoryShape Breast Implants are manufactured by Mentor Worldwide LLC. |
Thu, 13 Jun 2013 11:01:00 -0400
The U.S. Food and Drug Administration today expanded the approved use of Xgeva (denosumab) to treat adults and some adolescents with giant cell tumor of the bone (GCTB), a rare and usually non-cancerous tumor. |
Wed, 29 May 2013 14:34:00 -0400
The U.S. Food and Drug Administration today approved two new drugs, Tafinlar (dabrafenib) and Mekinist (trametinib), for patients with advanced (metastatic) or unresectable (cannot be removed by surgery) melanoma, the most dangerous type of skin cancer. |
Wed, 29 May 2013 11:59:00 -0400
The U.S. Food and Drug Administration announced today that injectable drugs used in total parenteral nutrition (TPN) in critical shortage will be imported into the United States and available to patients this week. |
Tue, 28 May 2013 17:07:00 -0400
iTrace for Blood Centers, (Version 1.0.924.0), the first application to use Radio Frequency Identification (RFID) technology in blood establishments to assist in enhancing blood safety by preventing the release of unsuitable blood components, was cleared today by the U.S. Food and Drug Administration. |
Recalls RSS
http://www.cpsc.gov/
Tue, 18 Jun 2013 11:30:00 GMT
The plastic bath seat with suction cups for children between 5 and 10 months old can tip over while a baby is in it. |
Tue, 18 Jun 2013 11:30:00 GMT
The plastic bath seat with suction cups for children between 5 and 10 months old can tip over while a baby is in it. |
Tue, 18 Jun 2013 11:30:00 GMT
The plastic bath seat with suction cups for children between 5 and 10 months old can tip over while a baby is in it. |
Thu, 13 Jun 2013 12:00:00 GMT
The dual-use heater/cooker’s regulator turns gas propane to liquid, which can flare easily. |
Thu, 13 Jun 2013 10:00:00 GMT
Metal flowers come off Stride Rite girl's "Joanna" sandals. |
|